文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

叉头框转录因子 D2 反义 RNA1 通过 miR-378g/载脂蛋白 B 促进口腔鳞状细胞癌中恶性细胞行为。

FOXD2-AS1 promotes malignant cell behavior in oral squamous cell carcinoma via the miR-378 g/CRABP2 axis.

机构信息

Department of Stomatology, The First Hospital of Putian City, 449 Nanmen West Road, Chengxiang District, Putian City, Putian, 351100, China.

Department of Neurology, The Affiliated Hospital of Putian University, Putian, 351100, China.

出版信息

BMC Oral Health. 2024 May 28;24(1):625. doi: 10.1186/s12903-024-04388-2.


DOI:10.1186/s12903-024-04388-2
PMID:38807101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11134640/
Abstract

BACKGROUND: Oral squamous cell cancer (OSCC) is a prevalent malignancy in oral cavity, accounting for nearly 90% of oral malignancies. It ranks sixth among the most common types of cancer worldwide and is responsible for approximately 145,000 deaths each year. It is widely accepted that noncoding RNAs participate cancer development in competitive regulatory interaction, knowing as competing endogenous RNA (ceRNA) network, whereby long non-coding RNA (lncRNA) function as decoys of microRNAs to regulate gene expression. LncRNA FOXD2-AS1 was reported to exert an oncogenic role in OSCC. Nevertheless, the ceRNA network mediated by FOXD2-AS1 was not investigated yet. This study aimed to explore the effect of FOXD2-AS1 on OSCC cell process and the underlying ceRNA mechanism. METHODS: FOXD2-AS1 expression in OSCC cells were determined via reverse transcription and quantitative polymerase chain reaction. Short hairpin RNA targeting FOXD2-AS1 was transfected into OSCC cells to silence FOXD2-AS1 expression. Then, loss-of-function experiments (n = 3 each assay) were performed to measure cell proliferation, apoptosis, migration, and invasion using colony formation, TdT-mediated dUTP Nick-End Labeling, wound healing and Transwell assays, respectively. RNA binding relation was verified by RNA immunoprecipitation and luciferase reporter assays. Rescue experiments were designed to validate whether FOXD2-AS1 affects cell behavior via the gene cellular retinoic acid binding protein 2 (CRABP2). Statistics were processed by GraphPad Prism 6.0 Software and SPSS software. RESULTS: FOXD2-AS1 was significantly upregulated in Cal27 and SCC9 cells (6.8 and 6.4 folds). In response to FOXD2-AS1 knockout, OSCC cell proliferation, migration and invasion were suppressed (approximately 50% decrease) while OSCC cell apoptosis was enhanced (more than two-fold increase). FOXD2-AS1 interacted with miR-378 g to alter CRABP2 expression. CRABP2 upregulation partly rescued (*p < 0.05, **p < 0.01, ***p < 0.001) the inhibitory impact of FOXD2-AS1 depletion on malignant characteristics of OSCC cells. CONCLUSION: FOXD2-AS1 enhances OSCC malignant cell behaviors by interacting with miR-378 g to regulate CRABP2 expression.

摘要

背景:口腔鳞状细胞癌(OSCC)是口腔中一种常见的恶性肿瘤,占口腔恶性肿瘤的近 90%。它在全球最常见的癌症类型中排名第六,每年导致约 14.5 万人死亡。人们普遍认为非编码 RNA 以竞争性调节相互作用的方式参与癌症的发生发展,即称为竞争内源性 RNA(ceRNA)网络,其中长非编码 RNA(lncRNA)作为 microRNA 的诱饵发挥作用,调节基因表达。已有报道称 lncRNA FOXD2-AS1 在 OSCC 中发挥致癌作用。然而,FOXD2-AS1 介导的 ceRNA 网络尚未被研究。本研究旨在探讨 FOXD2-AS1 对 OSCC 细胞过程的影响及其潜在的 ceRNA 机制。

方法:通过逆转录和定量聚合酶链反应检测 OSCC 细胞中的 FOXD2-AS1 表达。转染靶向 FOXD2-AS1 的短发夹 RNA 以沉默 FOXD2-AS1 表达。然后,通过集落形成、TdT 介导的 dUTP 末端标记、划痕愈合和 Transwell 分析分别进行失活功能实验(每组实验重复 3 次),以测量细胞增殖、凋亡、迁移和侵袭。通过 RNA 免疫沉淀和荧光素酶报告基因测定验证 RNA 结合关系。设计挽救实验以验证 FOXD2-AS1 是否通过基因细胞视黄酸结合蛋白 2(CRABP2)影响细胞行为。统计分析采用 GraphPad Prism 6.0 软件和 SPSS 软件进行。

结果:FOXD2-AS1 在 Cal27 和 SCC9 细胞中显著上调(6.8 和 6.4 倍)。FOXD2-AS1 敲除后,OSCC 细胞增殖、迁移和侵袭受到抑制(约 50%减少),而 OSCC 细胞凋亡增强(增加两倍以上)。FOXD2-AS1 与 miR-378g 相互作用改变了 CRABP2 的表达。CRABP2 的上调部分挽救了(*p<0.05,**p<0.01,***p<0.001)FOXD2-AS1 耗竭对 OSCC 细胞恶性特征的抑制作用。

结论:FOXD2-AS1 通过与 miR-378g 相互作用调节 CRABP2 表达,增强 OSCC 恶性细胞行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/11134640/73fefeda3a03/12903_2024_4388_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/11134640/d71f8940c0a4/12903_2024_4388_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/11134640/552d6f39a39d/12903_2024_4388_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/11134640/fd4fdd06ffb5/12903_2024_4388_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/11134640/74a0a748259a/12903_2024_4388_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/11134640/73fefeda3a03/12903_2024_4388_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/11134640/d71f8940c0a4/12903_2024_4388_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/11134640/552d6f39a39d/12903_2024_4388_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/11134640/fd4fdd06ffb5/12903_2024_4388_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/11134640/74a0a748259a/12903_2024_4388_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/11134640/73fefeda3a03/12903_2024_4388_Fig4_HTML.jpg

相似文献

[1]
FOXD2-AS1 promotes malignant cell behavior in oral squamous cell carcinoma via the miR-378 g/CRABP2 axis.

BMC Oral Health. 2024-5-28

[2]
LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway.

Cancer Genet. 2024-6

[3]
Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.

Mol Carcinog. 2022-9

[4]
Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.

Aging (Albany NY). 2020-12-9

[5]
LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.

J Investig Med. 2020-10

[6]
Long non-coding RNA BBOX1-antisense RNA 1 enhances cell proliferation and migration and suppresses apoptosis in oral squamous cell carcinoma via the miR-3940-3p/laminin subunit gamma 2 axis.

Bioengineered. 2022-4

[7]
LncRNA PCBP1-AS1 suppresses cell growth in oral squamous cell carcinoma by targeting miR-34c-5p/ZFP36 axis.

Cell Mol Biol (Noisy-le-grand). 2024-10-8

[8]
Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.

Biomed Pharmacother. 2019-7-29

[9]
Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma.

Dis Markers. 2021

[10]
Long non-coding RNA MAGEA4-AS1 binding to p53 enhances MK2 signaling pathway and promotes the proliferation and metastasis of oral squamous cell carcinoma.

Funct Integr Genomics. 2024-9-9

引用本文的文献

[1]
LncRNA SNHG5 promotes the invasion and proliferation of oropharyngeal squamous cell carcinoma by regulating the miR-21/PTEN signaling pathway.

Am J Transl Res. 2025-6-15

[2]
CRABP2 promotes metastasis and lipid droplet accumulation in non-small cell lung cancer by downregulating PLAAT4.

J Cancer. 2025-6-23

[3]
Exosomes carrying lncRNA FLG-AS1 overexpression vectors inhibit the tumorigenesis of oral squamous cell carcinoma via fat mass and obesity-associated protein-mediated m6A modification.

Cytotechnology. 2025-8

本文引用的文献

[1]
Advances in Diagnosis and Treatment of Basal Cell Carcinoma.

J Craniofac Surg.

[2]
CRABP2 affects chemotherapy resistance of ovarian cancer by regulating the expression of HIF1α.

Cell Death Dis. 2024-1-9

[3]
Cellular Retinoic Acid Binding Protein 2 (CRABP2), Up-regulated by HPV E6/E7, Leads to Aberrant Activation of the Integrin β1/FAK/ERK Signaling Pathway and Aggravates the Malignant Phenotypes of Cervical Cancer.

Biochem Genet. 2024-8

[4]
ENAH-202 promotes cancer progression in oral squamous cell carcinoma by regulating ZNF502/VIM axis.

Cancer Med. 2023-11

[5]
Extracellular vesicles promote activation of pro-inflammatory cancer-associated fibroblasts in oral cancer.

Front Cell Dev Biol. 2023-9-7

[6]
Oral health-related quality of life in patients with oral squamous cell carcinoma: A case-control study.

Dent Res J (Isfahan). 2023-3-28

[7]
CRABP2 Is Associated With Thyroid Cancer Recurrence and Promotes Invasion via the Integrin/FAK/AKT Pathway.

Endocrinology. 2022-10-23

[8]
Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer.

Cell Death Dis. 2022-10-4

[9]
DDX59-AS1 is a prognostic biomarker and correlated with immune infiltrates in OSCC.

Front Genet. 2022-8-23

[10]
Current trends of targeted therapy for oral squamous cell carcinoma.

J Cancer Res Clin Oncol. 2022-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索